Passage Bio
(NASDAQ) PASG
Passage Bio Financials at a Glance
Market Cap
$23.67M
Revenue (TTM)
$0.00
Net Income (TTM)
$45.52M
EPS (TTM)
$-14.44
P/E Ratio
-0.51
Dividend
$0.00
Beta (Volatility)
1.56 (High)
Dividend
$0.00
Beta (Volatility)
1.56 (High)
Price
$6.88
Volume
27,462.135
Open
$6.93
Price
$6.88
Volume
27,462.135
Open
$6.93
Previous Close
$7.38
Daily Range
$6.80 - $7.50
52-Week Range
$5.12 - $20.00
Dividend
$0.00
Beta (Volatility)
1.56 (High)
Price
$6.88
Volume
27,462.135
Open
$6.93
Previous Close
$7.38
Daily Range
$6.80 - $7.50
52-Week Range
$5.12 - $20.00
PASG News
PASG: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Passage Bio
Industry
Biotechnology
Sector
Health CareEmployees
24
CEO
William Chou, MD, MBA
Website
www.passagebio.comHeadquarters
Philadelphia, PA 19103, US
PASG Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-114%
Return on Capital
-1%
Return on Assets
-73%
Earnings Yield
-1.96%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$23.67M
Shares Outstanding
3.21M
Volume
27.46K
Short Interest
0.00%
Avg. Volume
56.39K
Financials (TTM)
Gross Profit
$728.00K
Operating Income
$43.15M
EBITDA
$42.42M
Operating Cash Flow
$31.51M
Capital Expenditure
$0.00
Free Cash Flow
$31.51M
Cash & ST Invst.
$46.30M
Total Debt
$24.01M
Passage Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$177.00K
+75.4%
Gross Margin
0.00%
N/A
Market Cap
$23.67M
N/A
Market Cap/Employee
$394.56K
N/A
Employees
60
N/A
Net Income
$12.98M
-2.0%
EBITDA
$10.16M
+17.4%
Quarterly Fundamentals
Net Cash
$22.29M
-56.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$20.44M
-6.2%
Short Term Debt
$3.57M
-3.3%
Return on Assets
-73.09%
N/A
Return on Invested Capital
-1.10%
N/A
Free Cash Flow
$6.48M
+23.4%
Operating Cash Flow
$6.48M
+23.3%